Soergel David
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Soergel David. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| MDGL | Chief Medical Officer | Award / Grant | 7,545 | — | — | May 15, 2025 |
| 0001429560 | Sr. VP,Clinical Dev. & CMO | Sale | 27,217 | $10.55 | $287,139 | Dec 10, 2015 |
| 0001429560 | Sr. VP, Clinical Development | Purchase | 500 | $3.97 | $1,985 | Dec 10, 2014 |
| 0001429560 | Sr. VP, Clinical Development | Purchase | 1,250 | $4.00 | $5,000 | Dec 10, 2014 |